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Under homeostatic conditions, dendritic cells (DCs) continuously patrol the intestinal
lamina propria. Upon antigen encounter, DCs initiate C-C motif chemokine receptor 7
(CCR7) expression and migrate into lymph nodes to direct T cell activation and differ-
entiation. The mechanistic underpinnings of DC migration from the tissues to lymph
nodes have been largely elucidated, contributing greatly to our understanding of DC
functionality and intestinal immunity. In contrast, the molecular mechanisms allowing
DCs to efficiently migrate through the complex extracellular matrix of the intestinal lam-
ina propria prior to antigen encounter are still incompletely understood. Here we show
that small intestinal murine CD11b+CD103+ DCs express Placenta-expressed transcript 1
(Plet1), a glycophoshatidylinositol (GPI)-anchored surface protein involved in migration of
keratinocytes during wound healing. In the absence of Plet1, CD11b+CD103+ DCs display
aberrant migratory behavior, and accumulate in the small intestine, independent of CCR7
responsiveness. RNA-sequencing indicated involvement of Plet1 in extracellular matrix-
interactiveness, and subsequent in-vitro migration assays revealed that Plet1 augments
the ability of DCs to migrate through extracellular matrix containing environments. In
conclusion, our findings reveal that expression of Plet1 facilitates homeostatic interstitial
migration of small intestinal DCs.
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Introduction
Most cells in the mammalian body are contained within a
singular environment throughout their life span, with movement
generally restricted to a microenvironment to which cells have
optimally adapted. This is in sharp contrasts to immune cells,
that migrate through highly divergent surroundings, ranging
from the fluidics of blood and lymph to the cell and matrix-dense
environments of peripheral organs [1]. The quintessential exam-
ple of migrating immune cells are dendritic cells (DCs). DCs
patrol peripheral tissues, efficiently navigating the extracellular
matrix (ECM) with which they are continuously interacting. Upon
antigen encounter, DCs become untethered from the ECM, gain
the ability to egress from peripheral tissues, enter the fluidic envi-
ronment of the lymph [2–4] and migrate to the draining lymph
nodes (LN) in a CCR7-dependent manner [5, 6]. A number of
mechanisms and molecules that allow tissue egress and entry into
lymph vessels upon DC maturation have been clarified in recent
years [5, 7]. In contrast, the mechanistic underpinnings that allow
immature DCs to efficiently surveil peripheral tissues are largely
unknown.
In order to accommodate efficient tissue egress and entry into
the draining lymphatics, activatied DCs in barrier tissues alter
their migratory machinery. In the skin, DC activation leads to
functional deactivation of cell adhesion and integrin receptors,
allowing for detachment from the ECM [8, 9]. Similarly, intestinal
DC activation leads to migration and tissue egress by mechanisms
independent of integrin interactions but driven by amoeboid-like
movement through the ECM [10].
There is evidence to suggest that microbiota-derived sig-
nals modulate homeostatic DC behaviour. Intestinal bacteria
can actively induce migration of CD103+ DCs into the intesti-
nal epithelial barrier [11, 12] and in Toll-like receptor (TLR)-
signalling deficient Myd88−/− mice, migration of CD103+ intesti-
nal DCs to gut-draining LN is aberrant [13].
Based on such associations between microbial signals and
interstitial DC positioning, we hypothesized that sensing of
microbiota-derived signals influences motility of immature DCs
within mucosal tissues. In this study, we identified expression of
Placenta-expressed transcript 1 (Plet1), a surface protein involved
in keratinocyte migration [14], on intestinal migratory DCs. Plet1
is an orphan Glycophoshatidylinositol (GPI)-anchored surface pro-
tein first identified as a protein recognized by the monoclonal
antibodies (mAbs) MTS20 and MTS24 [15] and expressed on var-
ious cells and organs, such as the early thymic epithelial cells [16],
mouse hair follicular keratinocyte progenitor cells [17], and major
duct epithelium [15, 18].
Using gene-targeted mice, unbiased transcriptomic profil-
ing and in vitro assays we show that Plet1 allows DCs to
efficiently migrate through ECM-rich environments, indepen-
dent of CCR7 ligation. Our work links microbial presence to
homeostatic DC functionality, and identifies a protein used by
the small intestinal immune system to modulate steady state
activity of sentinel dendritic cells in response to changing
environments.
Results
Plet1 marks migratory mucosal DCs and is regulated
by microbiota
Homeostatic interstitial migration of small intestinal DCs is likely
influenced by signals derived from the intestinal microbiota.
To identify microbiota-modulated DC-expressed molecules we
performed combinatorial in-silico analysis of publicly available
microarray datasets. We selected genes whose transcription was
upregulated in small intestinal tissue of germ-free mice at 4 or 30
days after conventionalization with total fecal microbial commu-
nity (GSE32513) [19] and which were overexpressed in intesti-
nal migratory CD11b+CD103+ DCs compared to CD11b−CD103+
DCs (GSE15907) [20]. This identified 20 genes (Fig. 1A and B)
3 of which (Plet1, Lgals9, and Celsr1) had previously been asso-
ciated with cell migration or cell adhesion (Supporting Informa-
tion Table 2). Interestingly, Plet1 (also known as MTS24 [15]
or AgK114 [21, 22]) has an important function in keratinocyte
migration during wound healing [14] and Plet1 expression on
small intestinal CD45+ hematopoietic cells was previously noted
[15]. We therefore analyzed Plet1 protein expression on mononu-
clear phagocytes in mouse small intestine. Histological analy-
ses revealed Plet1 expression on CD11c+ cells in small intes-
tine lamina propria (SI-LP), and in the mesenteric lymph nodes
(MLN) draining the small intestine (Fig. 1C). The presence of
CD11c+Plet1+ cells in both intestine and gut-draining lymph
nodes suggested that Plet1 could be expressed on a migrating
DC population. We therefore used a more elaborate labeling to
identify intestinal DCs by flow cytometry (gating in Supporting
Information Fig. 1, according to refs [23, 24]). This revealed that
Plet1 was expressed on CD11c+MHCII+ DCs, and absent from
cells expressing CD64, including monocytes and macrophages
(Supporting Information Fig. 2) [23]. Moreover, nearly all Plet1+
DCs were contained within the MHCIIhi migratory DC popula-
tion (Fig. 1D). In line with this expression on migrating DCs, the
frequency of Plet1-expressing cells within mucosal LNs was con-
sistently higher compared to peripheral LNs (Fig. 1E). Plet1 tran-
scripts and protein were undetectable in splenic DCs (data not
shown). Finally, to prove that Plet1 is expressed on DCs migrating
from the intestine to the draining LNs under homeostatic condi-
tions we analyzed the presence of Plet1+ DCs in CCR7−/− animals,
where migratory DCs fail to egress from the SI-LP [5]. While the
frequency of Plet1+ DCs in the SI-LP of CCR7−/− animals was simi-
lar to that of littermate control mice, CCR7−/− MLNwere devoid of
Plet1-expressing DCs (Fig. 1F and G). Together, these data iden-
tify the protein Plet1 as a marker for small intestinal migratory
DCs under steady state conditions.
CD11b+CD103+ DCs express Plet1 prior to intestinal
egress
Several small intestinal DC subsets have the ability to migrate to
the draining LNs under homeostasis [25]. Flow cytometry revealed
C© 2018 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
292 Julien J. Karrich et al. Eur. J. Immunol. 2019. 49: 290–301
Figure 1. Plet1 is expressed onmucosalmigratoryDCand regulated bymicrobiota. (A) Venndiagramshowing in-silico combinatorial transcriptome
analysis of differentially expressed genes between CD103+CD11b+ DC and CD103+CD11b− DC (a, blue circle; http://www.immgen.org), and ileum
of germ freemice 4 days (b, yellow circle) and 30 days after conventionalization (c, orange circle; from: [19]). (B) List of genes differentially expressed
in a, b, and c. (C) Immunofluorescence analysis of small intestinal tissue (SI-LP, left panels), and MLN (right panels) showing expression of Plet1
(green) and CD11c (red). Plet1+CD11c+ cells appear yellow (scale bar 200 μm). Images are from a single animal representative of 3 independently
analyzed mice. (D) Representative flow cytometric analysis showing percentages of Plet1+ cells within MHCIIhi migratory DC (red) and MHCIIint
resident DC (blue) isolated from MLN (for DC gating strategy see Supporting Information Fig. 1). Data are shown as mean + SEM and are pooled
from 2 independent experiments, 4–5 mice per experiment. Unpaired Mann-Whitney test, ***p < 0.001. (E) Frequency of Plet1-expressing CD11c+
DC. Data are shown asmean +SEM and are pooled from two independent experiments, 2–4mice per experiment. (F) Representative flow cytometry
analysis of Plet1 expression on DC in small intestinal lamina propria and MLN of CCR7−/− mice and controls. (G) Frequency of Plet1-expressing
DC in the lamina propria and MLN of CCR7−/− animals, compared to littermate controls. Data are shown as mean +SEM and are pooled from two
independent experiments, 2–3 mice per experiment. Unpaired Mann–Whitney test, **p < 0.01.
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Figure 2. Plet1 is expressed by intestinal
CD11b+CD103+ DC. (A) Distribution of Plet1
on small intestinal lamina propria (LP)-,
and MLN-DC populations was analyzed by
flow cytometry according to expression of
CD103 and CD11b (CD103−CD11b−, dotted
grey line; CD103+CD11b−, dotted black line;
CD103−CD11b+, gray line; CD103+CD11b+,
black line) (Gating as in Supporting Information
Fig. 1). (B) Frequency of Plet1+ cells within DC
subsets according to CD103 and CD11b in the
SI-LP (left panel) and in the MLN (right panel),
as shown in (A) For A and B: pooled from 2–3
independent experiments, 2–4 mice per group,
mean + SEM. (C) Flow cytometric assessment
of Plet1 expression on ex-vivo splenic CD11c+
DC stimulated with LPS (left panel, black line),
or with Imiquimod (right panel, black line), as
compared to unstimulated cells (grey filled his-
tograms) pooled from 2 independent experi-
ments, 3–4 mice per group. (D) Relative expres-
sion of Plet1 transcripts in ex-vivo splenic DC,
cultured overnight with or without LPS. Pooled
from 2 independent experiments, 1–2 mice per
group and showingmean+ SEM. (E)MFI of Plet1
expression on BMDC assessed by flow cytome-
try. 3 animals analyzed in a single experiment.
(Unpaired Mann–Whitney test, *p < 0.05, mean
+ SEM).
that Plet1 was mainly expressed by CD11b+CD103+ DCs, with
approximately 80% of these cells expressing Plet1 in the SI-LP
and approximately 60% in MLN (Fig. 2A and B). Since our in-
silico analysis suggested that Plet1 transcription was regulated
by microbial signals, we stimulated bone marrow-derived DCs
(BMDCs) and freshly isolated murine splenic DCs for 24 h with
ligands for Toll-like receptors (TLR)-4 and TLR7. Both ligands
increased expression of Plet1 on ex-vivo splenic DCs (Fig. 2C and
D). In addition, TLR4 stimulation induced Plet1 mRNA expres-
sion on in-vitro generated BMDC (Fig.e 2E). Collectively, these
findings identify Plet1 as a TLR-regulated surface protein prefer-
entially expressed on CD11b+CD103+ small intestinal DCs prior
to exit from the lamina propria.
Normal intestinal immune system development in
Plet1−/− mice
To investigate the function of Plet1 in-vivo we generated Plet1
knock-out mice by replacing part of exon 1 of the Plet1 gene with
a CreERT2-containing targeting cassette (Fig. 3A). Unfortunately,
none of the founder strains with disturbed Plet1 transcription
showed transcription of the CreERT2 insert, precluding the use of
the Cre recombinase, effectively generating a conventional knock-
out strain (Fig. 3B). Plet1−/− mice were viable, born at Mendelian
ratios and histological examination of the small intestine of
8 to 12 week old animals did not reveal any signs of spontaneous
pathology (Fig. 3C). To assess whether Plet1 deficiency affects dif-
ferentiation of T helper cell subsets we analyzed composition of
the SI-LP T cell pool. Frequencies of Foxp3 expressing regulatory
T cells (Fig. 3D), or T cells secreting IFNγ, IL-17A or IL-10 (Fig. 3E)
were similar in Plet1−/− mice compared to littermate controls. To
determine possible impact on B cell immunity we enumerated
germinal center B cells in Peyer’s patches as well as fecal IgA con-
tent (Fig. 3F and G). Again no differences were observed between
Plet1−/− mice and littermate controls. Together this shows that
Plet1 deficiency does not affect intestinal immune cell composi-
tion and does not lead to spontaneous intestinal pathology.
Plet1 alters steady state distribution of migratory
CD11b+CD103+ DCs in the small intestine
To define whether expression of Plet1 influences homeostatic
localization of DC, we analyzed CD103-expressing SI-LP cells in
Plet1−/− and control mice. Histological analyses of illeal sections
suggested an increase in CD103+CD3− cells within the lower
parts of the villi in Plet1−/− mice (Fig. 4A). To quantify this
difference, we analyzed total SI-LP by flow cytometry. Absence
of Plet1 resulted in a significant increase in the percentage of
total intestinal DCs (Fig. 4B and C) and this increase was mainly
due to an accumulation of CD11b+CD103+ DCs (Fig. 4C). Fre-
quencies of DCs in the MLN were comparable between the two
groups (Fig. 4D). To address whether this altered phenotype was
DC intrinsic, and to exclude any possible confounding effects of
Plet1 absence on tubular epithelial cells [21], we generated bone
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Figure 3. Normal intestinal immune system development in Plet1−/− mice. (A) Schematic representation of the targeting strategy for knock in-
mediated silencing of Plet1. (B) Plet1 expression on small intestinal DC isolated from Plet1+/− (gray line), or Plet1−/− (black line) mice was analyzed
by flow cytometry. >10 mice per genotype (C) Representative H&E staining of duodenal sections from Plet1+/− or Plet1−/− animals. 4–5 mice per
genotype from 2 independent experiments, scale bar 100 μm. (D) Frequency of FoxP3+ T cells within total SI-LP CD4+ T cells from Plet1+/− or
Plet1−/− animals. 2 independent experiments, 3 mice per group. (E) Frequency of IFNγ+, IL-17+, and IL-10+ producing CD4+ MLN T cells following
restimulation for 4 h with PMA/Ionomycin. Pooled data from 2 independent experiments with 4 mice per group. (Unpaired Mann–Whitney test,
mean + SEM) (F) Mean frequencies of CD38− germinal center (GC) B cells isolated from Plet1+/−, or Plet1−/− Peyer’s patches. Pooled data from 2
independent experiments with 3 mice per group. (Unpaired Mann-Whitney test, mean + SEM) (G) Quantification of IgA within total fecal content
of colons from Plet1−/− and littermate controls, normalized to weight. Pooled data from 2 independent experiments with 4–5 mice per group.
(Unpaired Mann-Whitney test, mean + SEM).
marrow chimeric mice using either Plet1−/− or WT bone marrow.
Analyses of DC subsets revealed that hematopoietic deficiency of
Plet1 resulted in an increased frequency of total DCs in the SI-LP,
that was concomitant with a diminished proportion of total DCs
in the MLN (Fig. 4E and F). Taken together, this indicates that
Plet1-deficiency alters homeostatic positioning of small intestinal
DCs.
Plet1 controls in-vitro DC migration through 3D
environments
The accumulation of intestinal CD11b+CD103+ DCs in the
absence of Plet1 could result from altered responsiveness to CCR7
ligands and subsequent reduced migration to the MLN. To directly
assess CCR7 responsiveness, we generated BMDCs from Plet1−/−
and littermate control bone marrow. Notably, BMDCs express
Plet1 (Fig. 2F), making this a suitable model to study functional
consequences of Plet1 expression. Generation and activation of
Plet1−/− BMDC was similar to controls (Supporting Information
Fig. 3A–D). The ability of BMDCs to migrate in a CCR7-dependent
manner was tested in trans-well assays. After 2 h, the number of
migrated BMDCs was comparable between Plet1−/− and heterozy-
gous or homozygous controls, indicating that absence of Plet1
does not reduce CCR7 responsiveness (Fig. 5A). We next took
an unbiased approach to identify transcriptional changes affected
by absence of Plet1 and compared FACS-sorted CD11b+CD103+
small intestinal lamina propria DCs from Plet1+/− and Plet1−/−
animals by RNA-sequencing (Fig. 5B). In the absence of Plet1,
66 genes were significantly altered, with the majority of genes
(62 genes) showing increased transcription in Plet1−/− DCs
(Supporting Information Table 3). This suggested that Plet1 is
predominantly involved in constraining gene expression (Fig. 5B).
Gene set enrichment analysis (GSEA) indicated enrichment of
gene sets associated with cell-cell interactions and interactions
with the ECM, as well as integrin signaling in the absence of Plet1
(Fig. 5C). This led us to hypothesize that Plet1 limits DCs - ECM
interactions, allowing for efficient migration through complex 3D
environments rich in ECM. To directly test this hypothesis we
interrogated the ability of Plet1−/− and control BMDCs to migrate
C© 2018 The Authors. European Journal of Immunology published by
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Figure 4. Plet1 deficiency alters homeostatic localization of intestinal CD11b+CD103+ DC. (A) Representative histology of illeal sections of Plet1+/−
and Plet1−/− mice. CD3 in red, CD103 in green. Scale bar: 100μm. Images from a single experiment representative of 2 experiments with 1–2 mice
per experiment (B) flow cytometry plots showing frequency of total DC in SI-LP of Plet1+/−, or Plet1−/− animals. (C) Frequency of total DC in small
intestinal lamina propria and (D) frequency of CD11b+CD103+ DC in small intestinal lamina propria. Pooled data of 2 independent experiments,
4–7 mice per group. Unpaired Mann–Whitney test, *p < 0.05, **p <0.005, mean + SEM. (E) Representative plots of SI-LP and MLN cells isolated from
WT or Plet1−/− bone marrow chimeric mice. (F) Frequency of total CD11c+MHCII+ DC in SI-LP (left panel), and MLN (right panel) of WT or Plet1−/−
bone marrow chimeric mice. Pooled data from 2 independent experiments, 5–6 mice per group. Unpaired Mann–Whitney test, ***p < 0.001, mean
+ SEM).
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Figure 5. Plet1 deficiency alters migration of DC in 3D collagen environments in-vitro. (A) Absolute cell numbers of migrated cells in response
to CCL19 using BMDC differentiated from Plet1−/− or littermate controls animals. Pooled data from 2 independent experiments, 1 mouse and 2
experimental repeats per experiment. (Unpaired Mann-Whitney test, mean + SEM) (B) Heat map showing significantly different genes between
CD11b+CD103+ DC isolated from Plet1-sufficient and Plet1-deficient mice, by RNA sequencing analysis. Single experiment with 2 animals per
genotype (C) Gene Set Enrichment Analysis highlighting a putative role for Plet1 in regulating interaction with the extracellular matrix. (D) CCL19-
dependent migration of Plet1−/− or control BMDC loaded in Collagen I matrix. (E) Chemokine independent migration of Plet1−/− or control BMDC
loaded in Collagen Imatrix. (Pooled data from 3 independent experiments using independent BMDC cultures and 4 experimental repeats. Unpaired
Mann–Whitney test, ***p < 0.001) (F) Chemokine independent migration of freshly isolated SI-LP DC loaded in Collagen I matrix. (Pooled data from
2 independent experiments with a single mouse and 4 experimental repeats per experiments. Unpaired Mann–Whitney test, *p < 0.05).
through a 3D collagen I matrix, the major component of the small
intestinal ECM in human and mouse [26], seeded in the upper
well of a trans-well chamber. In response to the CCR7 ligand
CCL19, Plet1−/− and Plet1+/+ BMDCs were equally capable of
navigating out of the collagen matrix (Fig. 5D). Since homeostatic
migration through tissues is CCR7 independent, we subsequently
determined the ability of BMDCs to exit the collagen I matrix in
the absence of CCR7 ligands. In this setup, Plet1−/− DCs had a
severe defect in migrating through the extracellular matrix, and
compared to control BMDC, only half of the cells egressed from the
C© 2018 The Authors. European Journal of Immunology published by
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collagen I matrix (Fig. 5E). Since BMDCs are likely not a faithful
representation of intestinal DCs [27], we next isolated total SI-LP
DCs from Plet1−/− and littermate control mice and seeded these
into collagen I containing trans-wells. Similar to BMDCs, Plet1-
deficient SI-LP DCs directly ex-vivo were blunted in their ability
to migrate through a 3D collagen environment, again showing a
2 fold reduction in number of cells migrating out of the collagen
gels (Fig. 5F). Altogether, our findings identify a role for Plet1 in
facilitating DC movement through ECM-rich 3D environments.
Discussion
The mechanistic underpinnings of CCR7-dependent migration of
activated, maturing DCs out of the intestine and into the draining
lymph nodes have been elucidated in detail [5, 7]. In sharp con-
trast, the factors that influence movement of DCs through barrier
tissues such as the intestine are much less defined. Here we identi-
fied the surface protein Plet1 as preferentially expressed on small
intestinal CD11b+CD103+ migratory DCs, functionally endowing
these cells with the ability to efficiently navigate ECM-rich 3D
environments ex-vivo.
Plet1 has been implicated in cellular migration in different
cell systems. During keratinocyte migration in in-vitro and in-vivo
models of wound healing, Plet1 alters the adhesion of leading edge
cells to Collagen type I and Collagen type IV [14, 22]. In our hands,
Plet1−/− small-intestinal DCs failed to migrate through Collagen
type I ECM, revealing a previously unappreciated parallel between
migration of DCs and keratinocytes. Our in-vitro experiments were
performed with isolated lamina propria DC as well as with GM-
CSF matured BMDC. It is important to realize that expression of
CCR7 on BMDC is lower in GM-CSF-derived cultures compared to
FLT3L-matured BMDC [28]. This might imply that the differences
observed could be even more pronounced when using alternative
methods of cell preparation.
Our data show that in the small intestinal immune system,
Plet1 expression is enriched on MHCIIhi migratory DCs and that
CD11b+CD103+ DCs are the main Plet1-expressing migratory DC
population in the steady-state small intestine.
In the absence of Plet1, CD11b+CD103+ DCs accumulate
in the intestinal lamina propria, even though these cells main-
tain functional CCR7 responses in-vitro. An explanation for this
accumulation might be in reduced motility of Plet1-deficient
CD11b+CD103+ DCs. A reduction in distance covered per time
unit due to altered locomotion could increase the average time to
antigen encounter and ensuing maturation with CCR7 induction.
This would prolong dwell-time of DCs in the small intestine and
ultimately result in an accumulation of cells in this compartment.
The small-intestinal adaptive immune system was unaltered in
Plet1−/− animals at steady state. However, our findings on Plet1
function do raise an intriguing possibility that warrants further
investigation. Reduced motility of Plet1-deficient DCs might not
only alter the time to antigen encounter, it might also negatively
affect the diversity of antigens encountered by individual DC. This
would result from the possibility that if individual DCs cover less
distance while patrolling the organ they might engulf antigens
from a smaller area of the intestine. Whether this is indeed the
case and whether this translates into altered or delayed immune
responses under infectious or inflammatory conditions is of clear
interest, but beyond the scope of the current study.
The exact molecular mechanism by which Plet1 modulates DC
motility remain undefined. Plet1 is a molecule whose expression
is very restricted. Notably, many of the Plet1 expressing cells are
epithelial by nature and exhibit stem or progenitor cell character-
istics. Plet1 is expressed by uterine luminal epithelium [29] and by
mammary gland epithelium [30]; furthermore, it demarcates very
distinct populations of progenitor cells in hair follicles [14, 31], in
pancreatic duct epithelium [15], and in the thymus [15, 16]. Inter-
estingly, both epithelial cells and progenitor cells critically depend
on interactions with ECM for their differentiation, survival and
adequate positioning [32]. It is therefore tempting to speculate
that Plet1 may be involved in regulating integrin–ECM interac-
tions. Our RNA-sequencing analysis revealed pathways involved
in interactions with the ECM, in line with previous data on ker-
atinocyte migration. Moreover, in-silico 3D structure prediction of
Plet1 using web-based prediction software (Phyre2) [33], reveals
a high structural homology with the N-terminal domain of the
secreted glycoprotein Reelin (Reelin-n; Supporting Information
Fig. 4) [34, 35], that is required for migration, differentiation, and
proliferation of neural stem cells in the brain [36, 37]. According
to the Immgen datasets [38], expression of Plet1 is not restricted to
intestinal DCs. It is also transcribed by skin epidermal/Langerhans
cells and lung CD103+ DCs. This suggests that Plet1-controlled tis-
sue migration could be a more common feature of mucosal DCs,
including skin and lung DCs, rather than being specific for the
small intestine.
In humans, Plet1 is poorly transcribed in epithelial cells [29],
yet a role for ECM-associated proteins in affecting human DC
function and migration exists [39]. Additional work is needed to
address Plet1 expression in the human intestinal immune system,
or to identify possible alternative molecules that can actively mod-
ulate ECM interactions to allow cellular motility within tissues.
Summarizing, we have identified Plet1 as a novel marker for
migrating CD11b+CD103+ small-intestinal DCs, regulated by TLR
signaling. Plet1 enhances DC motility in ECM-rich 3D environ-
ments and we propose that the intestinal innate immune system
uses expression of Plet1 to actively modulate its ability to scan
intestinal tissue for antigen.
Materials and methods
Mice
C57BL/6J wild-type (WT) mice were bred and maintained at
the Erasmus University Medical Center (Rotterdam, The Nether-
lands). CCR7−/− micewere bred andmaintained at the Biomedical
Services Unit at the University of Birmingham. Plet1−/− mice
were generated at the University of Edinburgh by inserting a
C© 2018 The Authors. European Journal of Immunology published by
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CreErt2 construct into exon 1 of the Plet1 gene, just downstream
of the Kozak sequence but upstream of the ATG. Animal exper-
iments were approved by local Animal Ethics Committees, and
performed in accordance with institutional guidelines. Age- and
gender-matched littermates were used whenever possible.
Antibodies
Monoclonal antibodies used were CD11c (HL3; BD), CD103 (2E7;
BioLegend), CD11b (M1/70; eBioscience), CD64 (X54-5/7.1;
BioLegend), MHC class II (M5/114.15.2; eBioscience), CD45 (30-
F11; BioLegend), CD45R (RA3-6B2; BD), CD8α (53-6.7; eBio-
science), CD197 (4B12; eBioscience), Plet1 (1D4), CD38 (90;
eBioscience), CD19 (1D3; eBioscience), CD95 (Jo2; BD), Donkey
anti-rat IgG (Life Technologies), CD4 (GK1.5; BD), Foxp3 (Fjk-
16s; eBioscience), IL-10 (JES5-16E3; eBioscience), IFNγ (XMG1.2;
BD), and IL-17A (TC11-18H10; BD Pharmingen). Zombie Aqua
Fixable viability kit (BioLegend) was used for dead cell exclusion.
Flow cytometry
Fc receptors were blocked by pre-incubation with normal mouse
serum. All stainings were performed in PBS containing 2% heat-
inactivated fetal calf serum (FCS) at 4°C, except for the CCR7
staining that was performed at 37°C. For intracellular Foxp3, IL-
10, IL-17A, and IFNγ, cells were stained for extracellular markers,
fixed, and permeabilized with Cytofix/Cytoperm solution (BD)
before intracellular staining. Cells were analyzed using a FACS
LSRII (BD Biosciences) and data was analyzed with FlowJo soft-
ware (FlowJo, LLC).
Radiation chimeras
8 week old C57BL/6J mice were irradiated 9 Gy and subsequently
reconstituted by i.v. injection of 1–2× 106 bone marrow cells from
either Plet1+/+ or Plet1−/− mice. Mice received oral antibiotics for
2 weeks after bone marrow transplantation, and were analyzed 8
weeks after reconstitution.
Isolation of cells from intestinal lamina propria
Isolated small intestine was opened longitudinally and washed
with cold HBSS containing 15 mM Hepes, pH 7.2. Tissues were
cut in 1 cm pieces and incubated in HBSS buffer containing 10%
FBS, 15 mM HEPES, 5 mM EDTA, and 1 mM DTT, pH 7.2, at 37°C
two times for 20min to remove epithelium and intraepithelial lym-
phocytes. Tissues were digested with 100 U/mL Collagenase VIII
(Sigma-Aldrich) in RPMI containing 10% FBS, 15 mMHEPES, 100
U/mL P/S, and 1 mM DTT, pH 7.2, at 37°C in a shaker two times
for 1 h. Supernatants were passed through a 100 μm cell strainer
and washed in cold HBSS. Pellets were suspended in 90% Percoll
(GE Healthcare), overlaid with 40% Percoll, and centrifuged at
1800 rpm for 20 min to allow separation of mononuclear cells by
density gradient. Interphase was washed and stained with conju-
gated antibodies. Lamina propria lymphocytes were analyzed by
flow cytometry (LSR II; BD), and Plet1+ DC were FACS-sorted
as LiveDead−CD45+B220−CD64−MHCII+CD11c+ (FACSAria III;
BD) (see Supporting Information Fig. 1 for full gating strategy).
Generation and in-vitro stimulation of BMDC
BMDC were generated from bone marrow suspensions harvested
from 8 to 12 weeks old C57BL/6, Plet1−/− mice, and litter-
mate controls. Briefly, bone marrow was flushed from femurs
and tibias, passed through a 100 μm mesh to remove fibrous
tissue, and red blood cells were lysed using IOTEST lysis solution
(Beckman Coulter). Cells were cultured at 0.3 × 106 cells/mL in
IMDM medium (GIBCO BRL) supplemented with 10% FCS, 2 mM
glutamine, 50 μM β2-mercaptoethanol, 100 IU/mL penicillin,
100 μg/mL streptomycin and 20 ng/mL Granulocyte-macrophage
colony-stimulating factor (GM–CSF; X63 supernatant) [40]. On
day 3 and on day 6, fresh GM-CSF-containing medium was added.
Floating differentiated BMDCwere isolated at day 7 and separated
from plate-adherent macrophages, and used for further experi-
ment. BMDC purity was determined by flow cytometry and was
consistently over 60%. For in-vitro stimulations, 1 × 106 BMDC
were cultured overnight in the presence of 5 ng/mL lipopolysac-
charide (LPS, Invivogen), or 10 ng/mL Imiquimod (Invivogen).
Trans-well migration assay
5 μm pore size trans-well plates (Corning Costar) were used.
Upper chambers were loaded with 5 × 104 BMDC, or FACS-sorted
CD11c+MHCII+ SI-LP DC in 200 μL of IMDM supplemented with
10% FBS and 20 ng/mL recombinant murine GM–CSF (cIMDM),
and the lower chambers with 500 μL of cIMDM with or without
50 ng/mL recombinant murine CCL19 (R&D Systems). To assess
cell migration through 3D collagen, the upper chamber was
loaded with 5 × 104 BMDC or sorted CD11c+MHCII+ SI-LP DC in
cIMDM mixed 1:2 with Collagen type I (Millipore) supplemented
with MEM 10X and NaHCO3 to pH 7.2. Final concentration of
Collagen type I was 3 mg/mL. Following incubation for 2 h,
migrated cells were isolated from the bottom compartment and
quantified by flow cytometry using Flow Count Fluorospheres
(Beckman Coulter).
IgA ELISA
Fecal pellets were stored in pre-weighed collection tubes, snap
frozen in liquid nitrogen, and kept at -80°C until extraction.
Samples were resuspended in PBS supplemented with pro-
tease inhibitor cocktail (Roche), and capture enzyme-linked
immunosorbent assay (ELISA; Ready-Set-Go!, eBioscience) was
C© 2018 The Authors. European Journal of Immunology published by
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used to quantify total concentrations of IgA in feces corrected to
weight. Mice used for fecal sampling were segregated by genotype
after weaning.
Transcript analysis
RNA was extracted using the NucleoSpin RNA XS kit (Machery-
Nagel). For quantitative PCR (qPCR), a Neviti Thermal Cycler
(Applied Biosystems) and DyNAmo Flash SYBR Green qPCR kit
(Finnzymes) were used, with the addition of MgCl2 to a final con-
centration of 4 mM. All reactions were performed in duplicate and
were normalized to the expression of Gapdh. Relative expression
was calculated by the cycling threshold (CT) method as -2CT. The
primer sequences can be found in Supporting Information Table 1.
RNA sequencing
cDNA was synthesized and amplified using SMARTer Ultra Low
RNA kit (Clontech Laboratories) following the manufacturer’s
protocol. Amplified cDNA was further processed according to
TruSeq Sample Preparation v.2 Guide (Illumina) and paired end-
sequenced (2 × 75 base pairs) on the HiSeq 2500 (Illumina).
Demultiplexing was performed using CASAVA software (Illu-
mina) and the adaptor sequences were trimmed with Cutadapt
(http://code.google.com/p/cutadapt/). Alignments against the
mouse genome (mm10) and analysis of differential expressed
genes were performed as previously described [41]. Cufflinks soft-
warewas used to calculate the number of fragments per kilobase of
exon per million fragments mapped (FPKM) for each gene. FPKM
values of Plet1−/− and Plet1+/+ DC were then compared to the
curated gene sets (C2) and the Gene Ontology gene sets (C7) of
the Molecular Signature Database (MSigDB) by GSEA [42] (Broad
Institute), using the Signal2Noise metric and 1000 phenotype-
based permutations.
Histology and immunohistochemistry
For histology, small intestinal tissue pieces were fixed in 4%
paraformaldehyde 4 h at room temperature, washed in 70%
ethanol and embedded in paraffin. Four-micrometer sections were
deparaffinized and stained with hematoxylin (Vector Laborato-
ries) and eosin (Sigma-Aldrich). For CD103 and CD3 detection,
endogenous peroxidases were blocked in 3% periodic acid in
deionized water for 10 min, and antigen retrieval was achieved by
microwave treatment in Citric Acid Based citrate buffer (pH 6.0).
Prior to staining, Fc receptors were blocked in 10% normal mouse
serum and 10% normal goat serum and Armenian hamster serum,
10 mM Tris buffer, 5 mM EDTA, 0.15 M NaCl, 0.25% gelatin,
and 0.05% Tween-20 (pH 8.0). Tissue sections were incubated
overnight at 4°C with primary antibodies (CD103: clone 2E7,
Biolegend; CD3: Polyclonal A0452, DAKO) in PBS supplemented
with 2% normal mouse serum. For immunohistochemistry, tis-
sues were frozen in Tissue-Tek O.C.T compound (Sakura Finetek
Europe B.V.) and stored at -80°C. Six μm sections cryosections
were fixed for 5 min in ice-cold aceton and air-dried for an addi-
tional 10min, and subsequently blocked with 5% normal mouse
serum and 5% normal donkey serum for 15min. Sections were
incubatedwith primary antibody Rat anti Plet-1 (1D4) and biotiny-
latedHamster anti CD11c (N418, Ebioscience) for 1 h at room tem-
perature, followed by a 30-min incubation with secondary donkey
anti-rat IgG labeled with AlexaFluor-488 and strepdavidin labeled
with AlexaFluor-594 (Molecular Probes). Sections were embed-
ded in Pro-long Gold with DAPI (Invitrogen) and analyzed on a
Leica DMRXA.
Statistical analysis
All analyses were performed in GraphPad Prism TM 7 soft-
ware. Statistical analyses were performed using unpaired Mann–
Whitney test. p values < 0.05 were considered significant. Data
are shown as mean ± SEM.
Venn diagrams were generated using Venny v2.1, (bioin-
fogp.cnb.csic.es/tools/venny)
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